[Federal Register Volume 88, Number 15 (Tuesday, January 24, 2023)]
[Notices]
[Pages 4286-4288]
[FR Doc No: 2023-01263]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2022-0047]

Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).

ACTION: Notice of applications for exemption; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 15 individuals
for an exemption from the prohibition in the Federal Motor Carrier
Safety Regulations (FMCSRs) against persons with a clinical diagnosis
of epilepsy or any other condition that is likely to cause a loss of
consciousness or any loss of ability to control a commercial motor
vehicle (CMV) to drive in interstate commerce. If granted, the
exemptions would enable these individuals who have had one or more
seizures and are taking anti-seizure medication to operate CMVs in
interstate commerce.

DATES: Comments must be received on or before February 23, 2023.

ADDRESSES: You may submit comments identified by the Federal Docket
Management System Docket No. FMCSA-2022-0047 using any of the following
methods:
     Federal eRulemaking Portal: Go to www.regulations.gov/,
insert the docket number (FMCSA-2022-0047) in the keyword box and click
``Search.'' Next, sort the results by ``Posted (Newer-Older),'' choose
the first notice listed, and click on the ``Comment'' button. Follow
the online instructions for submitting comments.
     Mail: Dockets Operations; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE, Washington, DC, 20590-0001, between 9 a.m.
and 5 p.m. ET Monday through Friday, except Federal Holidays.
     Fax:<PHONE_NUMBER>.
    To avoid duplication, please use only one of these four methods.
See the ``Public Participation'' portion of the SUPPLEMENTARY
INFORMATION section for instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, FMCSA, DOT, 1200 New Jersey Avenue SE, Room
W64-224, Washington, DC 20590-0001,<PHONE_NUMBER>,
[email protected]. Office hours are 8:30 a.m. to 5 p.m. ET Monday
through Friday, except Federal holidays. If you have questions
regarding viewing or submitting material to the docket, contact Dockets
Operations,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Submitting Comments

    If you submit a comment, please include the docket number for this
notice (Docket No. FMCSA-2022-0047), indicate the specific section of
this document to which each comment applies, and provide a reason for
each suggestion or recommendation. You may submit your comments and
material online or by fax, mail, or hand delivery, but please use only
one of these means. FMCSA recommends that you include your name and a
mailing address, an email address, or a phone number in the body of
your document so that FMCSA can contact you if there are questions
regarding your submission.
    To submit your comment online, go to www.regulations.gov/docket?D=FMCSA-2022-0047. Next, sort the results by ``Posted (Newer-
Older),'' choose the first notice listed, click the ``Comment'' button,
and type your comment into the text box on the following screen. Choose
whether you are submitting your comment as an individual or on behalf
of a third party and then submit.
    If you submit your comments by mail or hand delivery, submit them
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. FMCSA will consider all comments and
material received during the comment period.

B. Viewing Comments

    To view comments go to www.regulations.gov. Insert the docket

number FMCSA-2022-0047, in the keyword box and click ``Search.'' Next,
sort the results by ``Posted (Newer-Older),'' choose the first notice
listed, and click ``Browse Comments.'' If you do not have access to the
internet, you may view the docket online by visiting Dockets Operations
in Room W12-140 on the ground floor of the DOT West Building, 1200 New
Jersey Avenue SE, Washington, DC 20590-0001, between 9 a.m. and 5 p.m.
ET Monday through Friday, except Federal holidays. To be sure someone
is there to help you, please call<PHONE_NUMBER> or<PHONE_NUMBER>
before visiting Dockets Operations.

C. Privacy Act

    In accordance with 49 U.S.C. 31315(b)(6), DOT solicits comments
from the public on the exemption request. DOT posts these comments,
without edit, including any personal information the commenter
provides, to www.regulations.gov. As described in the system of records
notice DOT/ALL 14 (Federal Docket Management System), which can be
reviewed at https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices, the comments are searchable by the name of
the submitter.

II. Background

    Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption
from the FMCSRs for no longer than a 5-year period if it finds such
exemption would likely achieve a level of safety that is equivalent to,
or greater than, the level that would be achieved absent such
exemption. The statutes also allow the Agency to renew exemptions at
the end of the 5-year period. FMCSA grants medical exemptions from the
FMCSRs for a 2-year period to align with the maximum duration of a
driver's medical certification.
    The 15 individuals listed in this notice have requested an
exemption from the epilepsy and seizure disorders prohibition in 49 CFR
391.41(b)(8). Accordingly, the Agency will evaluate the qualifications
of each applicant to determine whether granting the exemption will
achieve the required level of safety mandated by statute.
    The physical qualification standard for drivers regarding epilepsy
found in Sec.  391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause the loss of consciousness or any loss of ability to
control a CMV.
    In addition to the regulations, FMCSA has published advisory
criteria \1\ to assist medical examiners (MEs) in determining whether
drivers with certain medical conditions are qualified to operate a CMV
in interstate commerce.
---------------------------------------------------------------------------

    \1\ These criteria may be found in APPENDIX A TO PART 391--
MEDICAL ADVISORY CRITERIA, section H. Epilepsy: Sec.  391.41(b)(8),
paragraphs 3, 4, and 5, which is available on the internet at
https://www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf.
---------------------------------------------------------------------------

    The criteria states that if an individual has had a sudden episode
of a non-epileptic seizure or loss of consciousness of unknown cause
that did not require anti-seizure medication, the decision whether that
person's condition is likely to cause the loss of consciousness or loss
of ability to control a CMV should be made on an individual basis by
the ME in consultation with the treating physician. Before
certification is considered, it is suggested that a 6-month waiting
period elapse from the time of the episode. Following the waiting
period, it is suggested that the individual have a complete
neurological examination. If the results of the examination are
negative and anti-seizure medication is not required, then the driver
may be qualified.
    In those individual cases where a driver has had a seizure or an
episode of loss of consciousness that resulted from a known medical
condition (e.g., drug reaction, high temperature, acute infectious
disease, dehydration, or acute metabolic disturbance), certification
should be deferred until the driver has recovered fully from that
condition, has no existing residual complications, and is not taking
anti-seizure medication.
    Drivers who have a history of epilepsy/seizures, off anti-seizure
medication, and seizure-free for 10 years, may be qualified to operate
a CMV in interstate commerce. Interstate drivers with a history of a
single unprovoked seizure may be qualified to drive a CMV in interstate
commerce if seizure-free and off anti-seizure medication for a 5-year
period or more.
    As a result of MEs misinterpreting advisory criteria as regulation,
numerous drivers have been prohibited from operating a CMV in
interstate commerce based on the fact that they have had one or more
seizures and are taking anti-seizure medication, rather than an
individual analysis of their circumstances by a qualified ME based on
the physical qualification standards and medical best practices.
    On January 15, 2013, FMCSA announced in a notice of final
disposition titled, ``Qualification of Drivers; Exemption Applications;
Epilepsy and Seizure Disorders,'' (78 FR 3069), its decision to grant
requests from 22 individuals for exemptions from the regulatory
requirement that interstate CMV drivers have ``no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause loss of consciousness or any loss of ability to
control a CMV.'' Since that time, the Agency has published additional
notices granting requests from individuals for exemptions from the
regulatory requirement regarding epilepsy found in Sec.  391.41(b)(8).
    To be considered for an exemption from the epilepsy and seizure
disorders prohibition in Sec.  391.41(b)(8), applicants must meet the
criteria in the 2007 recommendations of the Agency's Medical Expert
Panel (78 FR 3069).

III. Qualifications of Applicants

Andrew Briggs

    Andrew Briggs is a 43-year-old class A, B, C, and D commercial
driver's license (CDL) holder in Wisconsin. They have a history of
focal epilepsy and have been seizure free since 2010. They take anti-
seizure medication with the dosage and frequency remaining the same
since December 2011. Their physician states that they are supportive of
Andrew Briggs receiving an exemption.

Joel Clapper

    Joel Clapper is a 49-year-old class C license holder in Michigan.
They have a history of seizure disorder and have been seizure free
since 2005. They take anti-seizure medication with the dosage and
frequency remaining the same since November 2005. Their physician
states that they are supportive of Joel Clapper receiving an exemption.

Trent Clark

    Trent Clark is a 38-year-old class C license holder in
Pennsylvania. They have a history of seizure and have been seizure free
since 2007. They take anti-seizure medication with the dosage and
frequency remaining the same since 2015. Their physician states that
they are supportive of Trent Clark receiving an exemption.

John Girdley

    John Girdley is a 42-year-old class D license holder in Kentucky.
They have a history of epilepsy and have been seizure free since
September 2012. They take anti-seizure medication with the dosage and
frequency remaining the same since November 2014. Their physician
states that they are supportive of John Girdley receiving an exemption.

Larry Kirby

    Larry Kirby is a 36-year-old class A CDL holder in Missouri. They
have a history of epilepsy and have been seizure free since 2010. They
take anti-seizure medication with the dosage and frequency remaining
the same since May 2019. Their physician states that they are
supportive of Larry Kirby receiving an exemption.

Matthew Lynch

    Matthew Lynch is a 31-year-old class C license holder in
Pennsylvania. They have a history of seizure disorder and have been
seizure free since 2013. They take anti-seizure medication with the
dosage and frequency remaining the same since 2013. Their physician
states that they are supportive of Matthew Lynch receiving an
exemption.

Edward Malicki

    Edward Malicki is a 49-year-old class D license holder in New York.
They have a history of generalized epilepsy and have been seizure free
since 2002. They take anti-seizure medication with the dosage and
frequency remaining the same since 2003. Their physician states that
they are supportive of Edward Malicki receiving an exemption.

Jared Meyers

    Jared Meyers is a 30-year-old class R license holder in
Mississippi. They have a history of cryptogenic seizures and have been
seizure free since November 2007. They take anti-seizure medication
with the dosage and frequency remaining the same since November 2007.
Their physician states that they are supportive of Jared Meyers
receiving an exemption.

James Niemoller

    James Niemoller is a 45-year-old class C license holder in
Maryland. They have a history of epilepsy and have been seizure free
since May 1990. They take anti-seizure medication with the dosage and
frequency remaining the same since June 2013. Their physician states
that they are supportive of James Niemoller receiving an exemption.

Joshua Pattyn

    Joshua Pattyn is a 47-year-old class A CDL holder in Oregon. They
have a history of seizure disorder and have been seizure free since
1995. They take anti-seizure medication with the dosage and frequency
remaining the same since 1995. Their physician states that they are
supportive of Joshua Pattyn receiving an exemption.

Joe W. Porath

    Joe W. Porath is a 51-year-old class A CDL holder in Idaho. They
have a history of sequalae of cerebral infraction, unprovoked seizure
and have been seizure free since July 2017. They take anti-seizure
medication with the dosage and frequency remaining the same since
October 2017. Their physician states that they are supportive of Joe W.
Porath receiving an exemption.

Jon Rollins

    Jon Rollins is a 52-year-old class D license holder in Ohio. They
have a history of grand mal seizure disorder and have been seizure free
since 2006. They take anti-seizure medication with the dosage and
frequency remaining the same since 2006. Their physician states that
they are supportive of Jon Rollins receiving an exemption.

Garrett Sager

    Garrett Sager is a 25-year-old class C license holder in Iowa. They
have a history of epilepsy generalized tonic-clonic seizure and have
been seizure free since 2012. They take anti-seizure medication with
the dosage and frequency remaining the same since April 2019. Their
physician states that they are supportive of Garrett Sager receiving an
exemption.

Colin Trummer

    Colin Trummer is a 19-year-old class D license holder in Ohio. They
have a history of benign Rolandic seizure and have been seizure free
since 2011. They have not taken anti-seizure medication since 2013.
Their physician states that they are supportive of Colin Trummer
receiving an exemption.

Shawn Vanliew

    Shawn Vanliew is a 65-year-old class D license holder in Minnesota.
They have a history of epilepsy and have been seizure free since 1992.
They take anti-seizure medication with the dosage and frequency
remaining the same since 1992. Their physician states that they are
supportive of Shawn Vanliew receiving an exemption.

IV. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315(b), FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated under the DATES
section of the notice.

Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2023-01263 Filed 1-23-23; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register: July 30, 2009 (Volume 74, Number 145)]
[Notices]
[Page 38079-38080]
[DOCID:fr30jy09-114]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Office of the Secretary

[Docket No. DOT-OST-2008-0038]

Agency Information Collection Activities; New Information
Collection: Survey of Over-the-Road Bus Companies About Accessible
Transportation for Individuals With Disabilities

AGENCY: Office of the Secretary, DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, the
U.S. Department of Transportation, Office of the Secretary, announces
its plan to submit the Information Collection Request (ICR) described
below to the Office of Management and Budget (OMB) for its review and
approval. The new information collection is associated with a required
review pursuant to the Americans with Disabilities Act of 1990 (ADA),
implementing regulations for a Survey Over-the-Road Bus (OTRB)
Companies located at subpart H of 49 CFR part 37. The collected
information would assist DOT with any decision to modify or retain the
requirements contained in the ADA regulations. On April 22, 2008, the
Federal Motor Carrier Safety Administration (FMCSA) published a Federal
Register notice (at 73 FR 21685) allowing for a 60-day comment period
on a new ICR involving OTRBs. Two comments were received on this issue.

DATES: Please send your comments by August 31, 2009. OMB must receive
your comments by this date in order to act quickly on the ICR.

ADDRESSES: All comments should reference Federal Docket Management
System (FDMS) Docket Number DOT-OST-2008-0038. Interested persons are
invited to submit written comments on the proposed information
collection to the Office of Information and Regulatory Affairs, Office
of Management and Budget. Comments should be addressed to the attention
of the DOT FMCSA Desk Officer via electronic mail at oira_
<EMAIL_ADDRESS>or faxed to<PHONE_NUMBER>, or mailed to the
Office of Information and Regulatory Affairs, Office of Management and
Budget, Docket Library, Room 10102, 725 17th Street, NW., Washington,
DC 20503.

FOR FURTHER INFORMATION CONTACT: Mr. Peter Chandler, Federal Motor
Carrier Safety Administration, Office of Enforcement and Compliance,
Commercial Passenger Carrier Safety Division, 1200 New Jersey Avenue,
SE., Washington, DC 20590. Telephone:<PHONE_NUMBER>, or e-mail
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:
    Title: Survey of Over-the-Road Bus Companies About Accessible
Transportation for Individuals With Disabilities.
    Type of Information Collection Request: New information collection.
    Respondents: Private entities that operate over-the-road buses
(OTRBs) are primarily in the business of transporting people, and whose
operations affect commerce.
    Estimated Number of Respondents: 3,800.
    Estimated Time per Response: The estimated average burden per
response is 15 minutes.
    Estimated Total Annual Burden: 950 hours [(3,800 responses x 15
minutes per response)/60 minutes = 950 hours, or 1,900 if conducted
twice a year].
    Frequency of Response: This proposed information collection is
planned to be conducted only once or twice a year. A decision to
request the information for a second time would be based upon the
number of responses and the content of such responses to the initial
request.
    Background: On September 28, 1998, DOT issued final regulations, in
response to the Americans with Disabilities Act of 1990 (Pub. L. 101-
336, 104 Stat. 327, 42 U.S.C. 12101-12213 and 47 U.S.C. 225 and 611),
which required the accessibility of new OTRBs and accessible OTRB
service. The regulations require commercial OTRB operators to ensure
that passengers with disabilities can use OTRBs. DOT is required by 49
CFR 37.215 to review the various requirements within the ADA
regulations for OTRB companies. As part of this review, DOT is required
to consider certain factors including the percentage of accessible
ORTBs in the fleets of OTRB companies, the success of such companies at
meeting the requests of passengers with disabilities for accessible
OTRBs in a timely manner, ridership of OTRBs by passengers with
disabilities, volume of complaints by passengers with disabilities, and
the cost and service impacts of these requirements. After the review,
DOT is required to decide whether it is appropriate to somehow revise
the ADA regulations for OTRB companies (i.e., whether certain
provisions of the ADA regulations should be removed, modified, or made
more stringent).
    DOT has an information collection to cover this paperwork burden
under

OMB Control Number 2100-0019 to provide the Agency with data for use in
its review of the ADA related requirements and to monitor compliance by
OTRB companies. Such data are reported to FMCSA as the agency delegated
by DOT for this purpose. DOT needs additional data from OTRB companies
so that it can conduct an effective review and make an informed
regulatory policy decision on whether there is a need to revise, modify
or remove any of the ADA regulations involving OTRBs. Specifically,
data about bus fleet accessibility, fulfillment of accessible bus
requests, and ridership and volume of complaints by passengers with
disabilities, are needed from OTRB companies.
    DOT needs the new data to conduct the required review of the
various requirements within the ADA regulations for OTRB companies. The
Department, however, would need FMCSA to send letters to approximately
3,800 registered OTRB companies that will be asked to complete and
submit an enclosed form or make an on-line data submission via a
customized Web site.
    As noted above, FMCSA published inadvertently a notice in the
Federal Register with a 60-day public comment period to announce this
new proposed ICR on April 22, 2008. Two comments were received. Peter
Pan Bus Lines, Inc. and the American Bus Association questioned FMCSA's
authority to publish this new ICR when DOT had the authority to do so
under OMB Control Number 2100-0019. While this new information
collection request seeks different data from DOT's OMB Control Number
2100-0019 Information Collection, the initial 60-day Federal Register
notice on this issue should have been published by DOT, rather than by
FMCSA. It is true that FMCSA would administer this new information
collection upon OMB approval, but the Department and FMCSA determined
that the new information collection request should be issued by DOT
since it has the statutory authority to conduct the required review
under the ADA regulations.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including: (1) Whether the proposed
collection is necessary for the performance of DOT's functions; (2) the
accuracy of the estimated burden; (3) ways for the DOT to enhance the
quality, usefulness, and clarity of the collected information; and (4)
ways that the burden could be minimized without reducing the quality of
the collected information.

    Issued in Washington, DC, on July 22, 2009.
Patricia Lawton,
DOT PRA Clearance Officer, Office of the Chief Information Officer.
[FR Doc. E9-18013 Filed 7-29-09; 8:45 am]

BILLING CODE 4910-9X-P


[Federal Register Volume 81, Number 82 (Thursday, April 28, 2016)]
[Notices]
[Pages 25398-25399]
[FR Doc No: 2016-10007]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OLEM-2016-0182, FRL-9945-86-OLEM]

Agency Information Collection Activities; Proposed Collection;
Comment Request; 2017 Hazardous Waste Report, Notification of Regulated
Waste Activity, and Part A Hazardous Waste Permit Application and
Modification

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is planning to
submit the information collection request (ICR), 2017 Hazardous Waste
Report, Notification of Regulated Waste Activity, and Part A Hazardous
Waste Permit Application and Modification. (EPA ICR No. 0976.18, OMB
Control No. 2050-0024 to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act
(PRA) (44 U.S.C. 3501 et seq.). Before doing so, the EPA is soliciting
public comments on specific aspects of the proposed information
collection as described below. This is a proposed extension of the ICR,
which is currently approved through January 31, 2017. An Agency may not
conduct or sponsor and a person is not required to respond to a
collection of information unless it displays a currently valid OMB
control number.

DATES: Comments must be submitted on or before June 27, 2016.

ADDRESSES: Submit your comments, referencing by Docket ID No. EPA-HQ-
OLEM-2016-0024, online using www.regulations.gov (our preferred
method), by email to<EMAIL_ADDRESS>or by mail to: EPA Docket
Center, Environmental Protection Agency, Mail Code 28221T, 1200
Pennsylvania Ave. NW., Washington, DC 20460.
    EPA's policy is that all comments received will be included in the
public docket without change including any personal information
provided, unless the comment includes profanity, threats, information
claimed to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute.

FOR FURTHER INFORMATION CONTACT: Peggy Vyas, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460; telephone
number:<PHONE_NUMBER>; fax number:<PHONE_NUMBER>; email address:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Supporting documents which explain in detail
the information the EPA will be collecting are available in the public
docket for this ICR. The docket can be viewed online at
www.regulations.gov or in person at the EPA Docket Center, WJC West,
Room 3334, 1301 Constitution Ave. NW., Washington, DC. The telephone
number for the Docket Center is<PHONE_NUMBER>. For additional
information about EPA's public docket, visit http://www.epa.gov/dockets.
    Pursuant to section 3506(c)(2)(A) of the PRA, the EPA is soliciting
comments and information to enable it to: (i) Evaluate whether the
proposed collection of information is necessary for the proper
performance of the functions of the Agency, including whether the
information will have practical utility; (ii) evaluate the accuracy of
the Agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (iii) enhance the quality, utility, and clarity of the
information to be collected; and (iv) minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses. The
EPA will consider the comments received and amend the ICR as
appropriate. The final ICR package will then be submitted to OMB for
review and approval. At that time, the EPA will issue another Federal
Register notice to announce the submission of the ICR to OMB and the
opportunity to submit additional comments to OMB.
    Abstract: Section 3002 of RCRA requires hazardous waste generators
to

report, at least every 2 years, the quantity and nature of hazardous
waste generated and managed during that reporting cycle. Section 3004
requires treatment, storage, and disposal facilities (TSDFs) to report
any waste received. This is mandatory reporting. The information is
collected via the Hazardous Waste Report (EPA Form 8700-13 A/B). This
form is also known as the ``Biennial Report'' form.
    Section 3010 of RCRA requires any person who generates or
transports regulated waste or who owns or operates a facility for the
treatment, storage, or disposal of regulated waste to notify the EPA of
their activities, including the location and general description of
activities and the regulated wastes handled. The entity is then issued
an EPA Identification number. Entities use the Notification Form (EPA
Form 8700-12) to notify EPA of their hazardous waste activities. This
form is also known as the ``Notification'' form. On January 13, 2015,
EPA published the Definition of Solid Waste (DSW) final rule (80 FR
1694), which revised the regulations related to certain exclusions from
solid and hazardous waste regulation. Changes have been made to the
Notification form to reflect this final rule.
    Section 3005 of RCRA requires TSDFs to obtain a permit. To obtain
the permit, the TSDF must submit an application describing the
facility's operation. The RCRA Hazardous Waste Part A Permit
Application form (EPA Form 8700-23) defines the processes to be used
for treatment, storage, and disposal of hazardous wastes; the design
capacity of such processes; and the specific hazardous wastes to be
handled at the facility. This form is also known as the ``Part A''
form.
    Redline-strikeout versions of all three forms are available in the
docket for this notice.
    Form numbers: 8700-12, 8700-13A/B, and 8700-23.
    Respondents/affected entities: Business or other for-profit as well
as State, Local, or Tribal governments.
    Respondent's obligation to respond: Mandatory (RCRA Sections 3002,
3304, 3005, 3010).
    Estimated number of respondents: 50,692.
    Frequency of response: Biennially.
    Total estimated burden: 619,489 hours per year. Burden is defined
at 5 CFR 1320.03(b).
    Total estimated cost: $25,530,368 (per year), includes $285,088
annualized capital or operation & maintenance costs.
    Changes in estimates: The burden hours are likely to stay
substantially the same.

    Dated: April 19, 2016.
Barnes Johnson,
Director, Office of Resource Conservation and Recovery.
[FR Doc. 2016-10007 Filed 4-27-16; 8:45 am]
 BILLING CODE 6560-50-P